Skip to content
TrialScanner

NCT03519711

A Study of PTC923 (CNSA-001) in Primary Tetrahydrobiopterin (BH4) Deficient Participants With Hyperphenylalaninemia

Phase 1/Phase 2CompletedPTCTLead

Registry record

Lead sponsor
PTC Therapeutics
Conditions
BH4 Deficiency; Hyperphenylalaninemia
Primary completion
Oct 2, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03519711 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03519711: A Study of PTC923 (CNSA-001)... | TrialScanner